Market Domains & Opportunities

Avanti NanoSciences intends to develop a diverse portfolio of products including novel and proprietary instrument systems, Biomarker Detection and monitoring kits to support both research and diagnostic applications, and data analysis software.

Avanti nanoSciences intends to secure key strategic relationships early in the products' development and thereby leverage our partners' complementary resources and assets to ensure timely execution, freedom-to-operate, instrument development and manufacturing, and the ability to aggressively launch into the marketplace.

Avanti NanoSciences is focused on the Life Science market segments that consistently demand new and innovative technologies to further research, development and clinical capabilities. These markets already represent a $32 billion opportunity that is rapidly growing based on the availability of new and innovative enabling technologies. Capturing market share with attractive and sustainable returns on investment is definitely achievable.

The company will focus on a number of key market segments that have a high level of consumption of our products. These include biotechnology and pharmaceutical companies, CROs, CMOs, food safety organizations, clinical trials and diagnostics companies and hospital systems. The use of strategic partnerships oriented strictly for these market segmants will be the tool to create greater market share.